Pharmaceutical

Twist and Cancer Research Horizons sign antibody library platform deal

Twist Bioscience and CRUK innovation arm Cancer Research Horizons have signed an agreement for licensing a library of libraries.

Jul 19, 2023 - 20:00
Twist and Cancer Research Horizons sign antibody library platform deal
Twist Bioscience and CRUK innovation arm Cancer Research Horizons have signed an agreement for licensing a library of libraries.
Read the original article

Tags:

Previous Article

Flagship Pioneering collaborates with Pfizer to develop new therapies

Next Article

Novartis snaps up rare disease biotech DTx Pharma in $1bn deal

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Why do some women experience UTI pain with no clear infection? A mouse study offers clues

Why do some women experience UTI pain with no clear inf...

Mar 2, 2024

STAT+: Pharmalittle: We’re reading about a tossed PhRMA lawsuit, secrecy clauses, and more

STAT+: Pharmalittle: We’re reading about a tossed PhRMA...

Feb 13, 2024

Holoclara gains Series A financing for worm-derived therapies

Holoclara gains Series A financing for worm-derived the...

Jun 30, 2024